【摘要】 目的探讨医联体远程医疗在区域脑血管病快速化救治中的作用,研究健全脑血管疾病的分级诊疗体系和机制。方法选取我院2018年1月～2019年12月收治的100例急性脑卒中患者作为研究对象,按照随机数字表法分为远程医疗组(50例)和传统治疗组(50例)。远程医疗组利用远程医疗技术进行脑血管疾病诊治和转运,传统治疗组按照医联体内以往治疗方法进行脑血管疾病诊治和转运。比较两组的患者确诊时间、转运时间、从患者到达医院到静脉给予阿替普酶的时间(DNT)、患者从急诊接诊到完成股动脉穿刺时间(DPT)、平均住院时间、出院时和出院3个月后改良Rankin评分(m RS)。结果远程医疗组的患者确诊时间、转运时间、DNT、DPT、平均住院时间短于传统治疗组,差异有统计学意义(P<0.05);远程医疗组出院时和出院3个月后的mRS评分低于传统治疗组,差异有统计学意义(P<0.05)。结论医联体远程医疗建设能够促进建立一种连续快速规范的脑卒中诊治模式,提高脑血管疾病整体诊疗规范水平,保证脑血管病诊治同质化,降低急性脑卒中的致残率。更多还原

【Abstract】 Objective To explore the affect of medical association telemedicine in the rapid treatment of regional cerebrovascular diseases, to study and improve the hierarchical diagnosis system and mechanism of cerebrovascular diseases. Methods A total of 100 patients with acute stroke admitted to our hospital from January 2018 to December 2019 were selected as the research objects. According to random number table method, they were divided into the telemedicine group(50 cases) and the traditional treatment group(50 cases). Telemedicine technology was applied for the telemedicine group to diagnose and transport cerebrovascular diseases, and previous traditional treatment methods in the medical association was used for the traditional treatment group. The time of diagnosis, time of transfer, door-toneedle time(DNT), door-to-puncture time(DPT), average time for hospital stay, modify rankin scale(m RS) at the time of discharge and 3 months after discharge were compared between the two groups. Results The time of diagnosis, time of transfer, DNT, DPT and average hospitalization time in the telemedicine group were less than those in the traditional treatment group, the differences were statistically significant(P<0.05). The m RS score of the telemedicine group at discharge and 3 months after discharge were lower than those of the traditional treatment group, the differences were statistically significant(P<0.05). Conclusion The setup of medical association telemedicine can promote the establishment of a continuous, rapid and standardized mode of diagnosis and treatment of stroke disease, improve the overall level of diagnosis and treatment of cerebrovascular diseases, ensure the homogeneity of diagnosis and treatment of cerebrovascular diseases, and reduce the disability rate of acute stroke disease.更多还原